Ningbo David Medical Device Co., Ltd. (SHE:300314)
14.18
+0.12 (0.85%)
At close: Jan 23, 2026
SHE:300314 Revenue
Ningbo David Medical Device had revenue of 141.40M CNY in the quarter ending September 30, 2025, with 3.13% growth. This brings the company's revenue in the last twelve months to 516.76M, down -8.09% year-over-year. In the year 2024, Ningbo David Medical Device had annual revenue of 527.03M, down -14.76%.
Revenue (ttm)
516.76M
Revenue Growth
-8.09%
P/S Ratio
7.90
Revenue / Employee
564.14K
Employees
916
Market Cap
4.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 527.03M | -91.27M | -14.76% |
| Dec 31, 2023 | 618.30M | 112.26M | 22.18% |
| Jan 1, 2023 | 506.04M | 31.90M | 6.73% |
| Jan 1, 2022 | 474.13M | 14.60M | 3.18% |
| Dec 31, 2020 | 459.53M | 103.18M | 28.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.05B |
| Getein Biotech | 1.04B |
| Shanghai Kinetic Medical | 1.02B |
| Zhejiang Orient Gene Biotech | 842.11M |
| Dirui Industrial | 511.11M |
| Chison Medical Technologies | 449.62M |
| Nanjing Medlander Medical Technology | 437.82M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |